Skip to main content
. Author manuscript; available in PMC: 2022 Apr 11.
Published in final edited form as: Nature. 2021 Nov 10;600(7888):302–307. doi: 10.1038/s41586-021-04083-0

Extended Figure 8. Transcriptomic landscape of splenic NKT cells in responses to agonists.

Extended Figure 8.

(A) A heatmap shown with the Euclidean distances between different treatment groups. (B) Transcriptomic profile comparison of SB2217, SB2219 and OCH. (C) Pathway enrichment analysis of SB2217 reveals increased expression of immunoregulatory pathways in NKT cells when compared to vehicle or SB2219.